PharmaJet

PharmaJet is a medical technology company based in Golden, Colorado, founded in 2005 by Kathleen Callender. The company focuses on developing needle-free injection technology to enhance the safety and accessibility of vaccines and pharmaceuticals. Its innovative needle-less injector delivers vaccines through a high-velocity stream of liquid, eliminating the risks associated with traditional needles and reducing sharps waste. PharmaJet's flagship products include the Tropis intradermal injector, used for vaccines like polio and MMR, and the Stratis device, designed for intramuscular and subcutaneous injections. The company has formed over 80 global partnerships and has supplied tens of millions of needle-free syringes for vaccination programs worldwide. Notable customers include the World Health Organization and Seqirus. In 2023, PharmaJet received a strategic investment from the Daicel Corporation, furthering its mission to improve vaccine delivery and expand access to essential pharmaceuticals.

• Employees 34
• Founded 2005
• Annual Revenue $13500000
• Total Funding $29733492